Wilson and colleagues observed that loss of SMARCB1 (SNF5) triggers EZH2 expression, broad H3K27-trimethylation, subsequent repression of Polycomb target genes finally resulting in tumor formation. This evidence concerns the gene EZH2 and neoplasm.